These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mangiferin alleviates trimethylamine-N-oxide (TMAO)-induced atherogenesis and modulates gut microbiota in mice. He Z, Zhu H, Liu J, Kwek E, Ma KY, Chen ZY. Food Funct; 2023 Oct 16; 14(20):9212-9225. PubMed ID: 37781894 [Abstract] [Full Text] [Related]
25. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. Chen ML, Yi L, Zhang Y, Zhou X, Ran L, Yang J, Zhu JD, Zhang QY, Mi MT. mBio; 2016 Apr 05; 7(2):e02210-15. PubMed ID: 27048804 [Abstract] [Full Text] [Related]
26. Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors. Petriello MC, Hoffman JB, Sunkara M, Wahlang B, Perkins JT, Morris AJ, Hennig B. J Nutr Biochem; 2016 Jul 05; 33():145-53. PubMed ID: 27155921 [Abstract] [Full Text] [Related]
27. Gut microbiome and metabolomic profiles reveal the antiatherosclerotic effect of indole-3-carbinol in high-choline-fed ApoE-/- mice. He Y, Zhu Y, Shui X, Huang Z, Li K, Lei W. Phytomedicine; 2024 Jul 05; 129():155621. PubMed ID: 38678950 [Abstract] [Full Text] [Related]
28. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota. Hoyles L, Jiménez-Pranteda ML, Chilloux J, Brial F, Myridakis A, Aranias T, Magnan C, Gibson GR, Sanderson JD, Nicholson JK, Gauguier D, McCartney AL, Dumas ME. Microbiome; 2018 Apr 20; 6(1):73. PubMed ID: 29678198 [Abstract] [Full Text] [Related]
29. Polyphenols from hickory nut reduce the occurrence of atherosclerosis in mice by improving intestinal microbiota and inhibiting trimethylamine N-oxide production. Jiang C, Wang S, Wang Y, Wang K, Huang C, Gao F, Peng Hu H, Deng Y, Zhang W, Zheng J, Huang J, Li Y. Phytomedicine; 2024 Jun 20; 128():155349. PubMed ID: 38522315 [Abstract] [Full Text] [Related]
30. Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice. Chung RWS, Wang Z, Bursill CA, Wu BJ, Barter PJ, Rye KA. PLoS One; 2017 Jun 20; 12(12):e0189523. PubMed ID: 29240800 [Abstract] [Full Text] [Related]
31. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure. Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, Polhemus DJ, Tang WH, Wu Y, Hazen SL, Lefer DJ. Circ Heart Fail; 2016 Jan 20; 9(1):e002314. PubMed ID: 26699388 [Abstract] [Full Text] [Related]
32. Bifidobacterium breve and Bifidobacterium longum Attenuate Choline-Induced Plasma Trimethylamine N-Oxide Production by Modulating Gut Microbiota in Mice. Wang Q, Guo M, Liu Y, Xu M, Shi L, Li X, Zhao J, Zhang H, Wang G, Chen W. Nutrients; 2022 Mar 14; 14(6):. PubMed ID: 35334879 [Abstract] [Full Text] [Related]
33. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. Zhu W, Buffa JA, Wang Z, Warrier M, Schugar R, Shih DM, Gupta N, Gregory JC, Org E, Fu X, Li L, DiDonato JA, Lusis AJ, Brown JM, Hazen SL. J Thromb Haemost; 2018 Sep 14; 16(9):1857-1872. PubMed ID: 29981269 [Abstract] [Full Text] [Related]
34. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice. Zhang W, Miikeda A, Zuckerman J, Jia X, Charugundla S, Zhou Z, Kaczor-Urbanowicz KE, Magyar C, Guo F, Wang Z, Pellegrini M, Hazen SL, Nicholas SB, Lusis AJ, Shih DM. Sci Rep; 2021 Jan 12; 11(1):518. PubMed ID: 33436815 [Abstract] [Full Text] [Related]
35. Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality. Su C, Li X, Yang Y, Du Y, Zhang X, Wang L, Hong B. Nutr Diabetes; 2021 Jul 31; 11(1):27. PubMed ID: 34389700 [Abstract] [Full Text] [Related]
36. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, DiDonato AJ, Fu X, Hazen JE, Krajcik D, DiDonato JA, Lusis AJ, Hazen SL. Cell; 2015 Dec 17; 163(7):1585-95. PubMed ID: 26687352 [Abstract] [Full Text] [Related]
38. Dietary titanium dioxide particles (E171) promote diet-induced atherosclerosis through reprogramming gut microbiota-mediated choline metabolism in APOE-/- mice. Zhu X, Zhao L, Wang Y, Hu X, Zhu Y, Yang X. J Hazard Mater; 2022 Aug 15; 436():129179. PubMed ID: 35739712 [Abstract] [Full Text] [Related]
39. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis. Yang W, Zhang S, Zhu J, Jiang H, Jia D, Ou T, Qi Z, Zou Y, Qian J, Sun A, Ge J. J Mol Cell Cardiol; 2019 Sep 15; 134():119-130. PubMed ID: 31299216 [Abstract] [Full Text] [Related]
40. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure. Organ CL, Li Z, Sharp TE, Polhemus DJ, Gupta N, Goodchild TT, Tang WHW, Hazen SL, Lefer DJ. J Am Heart Assoc; 2020 May 18; 9(10):e016223. PubMed ID: 32390485 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]